150 related articles for article (PubMed ID: 25863299)
1. Three-dimensional guided renal denervation: Carrying coals to Newcastle?
Xiao Y; Dong B; Long D; Zhou S; Liu Q
Int J Cardiol; 2015; 187():545-6. PubMed ID: 25863299
[No Abstract] [Full Text] [Related]
2. Chronic kidney disease: role of sympathetic nervous system activation and potential benefits of renal denervation.
Hering D; Esler MD; Schlaich MP
EuroIntervention; 2013 May; 9 Suppl R():R127-35. PubMed ID: 23732145
[TBL] [Abstract][Full Text] [Related]
3. Beyond blood pressure: percutaneous renal denervation for the management of sympathetic hyperactivity and associated disease states.
McArdle MJ; deGoma EM; Cohen DL; Townsend RR; Wilensky RL; Giri J
J Am Heart Assoc; 2015 Mar; 4(3):e001415. PubMed ID: 25801757
[No Abstract] [Full Text] [Related]
4. Acute effect of renal sympathetic denervation on blood pressure in refractory hypertensive patients with chronic kidney disease.
Kiuchi MG; Chen S; Graciano ML; Carreira MA; Kiuchi T; Andrea BR; Lugon JR
Int J Cardiol; 2015; 190():29-31. PubMed ID: 25912114
[No Abstract] [Full Text] [Related]
5. Resistant hypertension: is renal denervation the current treatment of choice?
Reddi AS
Clin Exp Hypertens; 2014; 36(8):525-30. PubMed ID: 24678737
[TBL] [Abstract][Full Text] [Related]
6. Improvement of the renal function after renal sympathetic denervation in refractory hypertensive patients with chronic kidney disease: possible predictors.
Kiuchi MG; Graciano ML; Chen S; Carreira MA; Kiuchi T; Andrea BR; Lugon JR
Int J Cardiol; 2015 Nov; 199():10-2. PubMed ID: 26173167
[No Abstract] [Full Text] [Related]
7. Improvement of renal function after renal sympathetic denervation in CKD patients with controlled vs. uncontrolled hypertension.
Kiuchi MG; Chen S
Int J Cardiol; 2016 Nov; 223():494-496. PubMed ID: 27544613
[No Abstract] [Full Text] [Related]
8. Renal denervation: expanding the indication.
Daemen J; Mahfoud F
EuroIntervention; 2013 May; 9 Suppl R():R101-4. PubMed ID: 23732139
[No Abstract] [Full Text] [Related]
9. Renal failure after renal sympathetic ablation in a patient with chronic kidney disease--which came first, the chicken or the egg?
Schneider S; Baumann M; Lefeldt S; Laugwitz KL; Heemann U
Int J Cardiol; 2013 Sep; 167(6):e177-8. PubMed ID: 23647587
[No Abstract] [Full Text] [Related]
10. A 78-year-old female patient with severe resistant hypertension and chronic kidney disease stage 5 treated by renal denervation.
Morelli S; Tanzilli G; Farina L; Rubini G; Ralli G; Ceccotti P; De Marzio P; Cicconetti P; D'Ambrosio MT; Mangieri E
Blood Press Monit; 2014 Jun; 19(3):187-8. PubMed ID: 24797268
[No Abstract] [Full Text] [Related]
11. Pathophysiology of resistant hypertension in chronic kidney disease.
Campese VM
Semin Nephrol; 2014; 34(5):571-6. PubMed ID: 25416666
[TBL] [Abstract][Full Text] [Related]
12. Renal sympathetic denervation for treatment resistant hypertension.
Kok HK; Wong L; Loo B; Torreggiani WC
Ir Med J; 2013 Jan; 106(1):5-6. PubMed ID: 23472366
[No Abstract] [Full Text] [Related]
13. Three-dimensional guided renal denervation to treat drug-resistant arterial hypertension in a patient with renal insufficiency.
Lewalter T; Brodherr T
Hypertension; 2012 Oct; 60(4):e33. PubMed ID: 22914794
[No Abstract] [Full Text] [Related]
14. Eligibility for renal denervation in patients with resistant hypertension: when enthusiasm meets reality in real-life patients.
Savard S; Frank M; Bobrie G; Plouin PF; Sapoval M; Azizi M
J Am Coll Cardiol; 2012 Dec; 60(23):2422-4. PubMed ID: 23141491
[No Abstract] [Full Text] [Related]
15. Effects of renal denervation with a standard irrigated cardiac ablation catheter on blood pressure and renal function in patients with chronic kidney disease and resistant hypertension.
Kiuchi MG; Maia GL; de Queiroz Carreira MA; Kiuchi T; Chen S; Andrea BR; Graciano ML; Lugon JR
Eur Heart J; 2013 Jul; 34(28):2114-21. PubMed ID: 23786861
[TBL] [Abstract][Full Text] [Related]
16. Potential new indications and future studies.
Sudano I; Noll G; Luscher TF
EuroIntervention; 2013 May; 9 Suppl R():R155-60. PubMed ID: 23732149
[TBL] [Abstract][Full Text] [Related]
17. Renal sympathetic denervation for the treatment of resistant hypertension with chronic renal failure: first-in-man experience.
Luo D; Zhang X; Lu CZ
Chin Med J (Engl); 2013 Apr; 126(7):1392-3. PubMed ID: 23557581
[No Abstract] [Full Text] [Related]
18. Renal denervation: should we still hang in there?
Hao Y; Lu Z
Int J Cardiol; 2014 Oct; 176(3):1255-6. PubMed ID: 25129307
[No Abstract] [Full Text] [Related]
19. Renal sympathetic denervation for resistant hypertension in a child after aortic coarctation surgery.
Buchhorn R; Ziemer G; Jetter HM; M Borst M; Selbach J
Int J Cardiol; 2014 Apr; 172(3):e447-8. PubMed ID: 24491868
[No Abstract] [Full Text] [Related]
20. Ambulatory blood pressure may be designed as the primary efficacy outcome in clinical trials on renal denervation.
Wang Y
Int J Cardiol; 2014 Oct; 176(3):1262-3. PubMed ID: 25115259
[No Abstract] [Full Text] [Related]
[Next] [New Search]
